Avalon Pharma (Middle East Pharmaceutical)
4016.SR
#7334
Rank
NZ$1.01 B
Marketcap
NZ$28.98
Share price
2.05%
Change (1 day)
-49.94%
Change (1 year)

Financial Statements

Thumbnail Avalon Pharma (Middle East Pharmaceutical) Financial Statement 2023

Financial Statement 2023

Language: English

View Financial Statement